Ubiquitin ligase E6-AP and its role in human disease

Biochemical Society Transactions

Volumn 36, Issue 5, 2008, Pages 797-801

  Matentzoglu, Konstantin ^a   Scheffner, Martin ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Angelman syndrome; E6 oncoprotein; E6 associated protein (E6 AP); Human papillomavirus (HPV); Neurodevelopmental disorder; Ubiquitin ligase

Indexed keywords

UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E6 ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

CARCINOGENESIS; CONFERENCE PAPER; CYTOTOXICITY; DISEASE COURSE; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HAPPY PUPPET SYNDROME; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN TARGETING; RNA INTERFERENCE; UTERINE CERVIX CANCER; WART VIRUS;

ANGELMAN SYNDROME; ANIMALS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; HUMANS; MICE; MICE, KNOCKOUT; ONCOGENE PROTEINS, VIRAL; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 53849136261     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360797     Document Type: Conference Paper

References (51)

1. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and F6-AP complex functions as a ubiquitin-protein ligase in the ubiquitylation of p53. Cell 75, 495-505
2. Huibregtse, J.M., Scheffner, M., Beaudenon, S. and Howley, P.M. (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. U.S.A. 92, 2563-2567
3. Scheffner, M., Nuber, U. and Huibregtse, J.M. (1995) Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83
4. Nakao, M., Sutcliffe, J.S., Durtschi, B., Mutirangura, A., Ledbetter, D.H. and Beaudet, A.L. (1994) imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D155225E). Hum. Mol. Genet. 3, 309-315
5. Nicholls, R.D. and Knepper, J.L. (2001) Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2, 153-175
6. Kishino, T., Lalande, M. and Wagstaff, J. (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73
7. Matsuura, T., Sutcliffe, J.S., Fang, P., Galjaard, R.J., Jiang, Y.H., Benton, C.S., Rommens, J.M. and Beaudet, A.L. (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15, 74-77
8. Yamamoto, Y., Huibregtse, J.M. and Howley, P.M. (1997) The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41, 263-266
9. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342-350
10. Scheffner, M. and Whitaker, N.J. (2003) Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13, 59-67
11. Mantovani, F. and Banks, L. (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20, 7874-7887
12. Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13, 775-784
13. Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13, 4918-4927
14. Be, X., Hong, Y., Wei, J., Androphy, E.J., Chen, J.J. and Baleja, J.D. (2001) Solution structure determination and mutational analysis of the papillomavirus E6 interacting pepticle of E6AP. Biochemistry 40, 1293-1299
15. Nakagawa, S. and Huibregtse, J.M. (2000) Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 20, 8244-8253
16. Gewin, L., Myers, H., Kiyono, T. and Galloway, D.A. (2004) Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18, 2269-2282
17. Töpffer, S., Müller-Schiffmann, A., Matentzoglu, K., Scheffner, M. and Steger, G. (2007) Protein tyrosine phosphatase H1 is a target of the E6 oncoprotein of high-risk genital human papillomaviruses. J. Gen. Virol. 88 29S6-2965
18. Kuballa, P., Matentzoglu, K. and Scheffner, M. (2007) The role of the ulbiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J. Biol. Chem. 5, 65-71
19. Jing, M., Bohl, J., Brimer, N., Kinter, M. and Vande Pol, S.B. (2007) Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins. J. Virol. 81, 2231-2239
20. Gao, Q., Kumar, A., Singh, L., Huibregtse, J.M., Beaudenon, S., Srinivasan, S., Wazer, D.E., Band, H. and Band, V. (2002) Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res. 62, 3315-3321
21. Pan, H. and Griep, A.E. (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or F7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8, 1285-1299
22. Simonson, S.J., Difilippantonio, M.J. and Lambert, P.F. (2005) Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res. 65, 8266-8273
23. Beer-Romero, P., Glass, S. and Rolfe, M. (1997) Antisense targeting of F6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14, 595-602
24. Kim, Y., Cairns, M.J., Marouga, R. and Sun, L.Q. (2003) E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes. Cancer Gene Ther. 10, 707-716
25. Kelley, M.L., Keiger, K.E., Lee, C.J. and Huibregtse, J.M. (2005) The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J. Virol. 79, 3737-3747
26. Hengstermann, A., D'silva, M.A., Kuballa, P., Butz, K., Hoppe-Seyler, F. and Scheffner, M. (200S) Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J. Virol. 79, 9296-9300
27. Kao, W.H., Beaudenon, S.L., Talis, A.L., Huibregtse, J.M. and Howley, P.M. (2000) Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 74, 6408-6417
28. Angelman, H. (1965) 'Puppet children': a report of three cases. Dev. Med. Child Neurol. 7, 681-688
29. Clayton-Smith, J. and Laan, L. (2003) Angelman syndrome: a review of the clinical and genetic aspects. J. Med. Genet. 40, 87-95
30. Amos-Landgraf, J.M., Ji, Y., Gottlieb, W., Depinet, T., Wandstrat, A.E., Cassidy, S.B., Driscoll, D.J., Rogan, P.K., Schwartz, S. and Nicholls, R.D. (1999) Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal bfeakpoints. Am. J. Hum. Genet. 65, 370-396
31. Vu, T.H. and Hoffman, A.R. (1997) Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat. Genet. 17, 12-13
32. Rougeulle, C., Glatt, H. and Lalande, M. (1997) The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat. Genet. 17, 14-15
33. Fang, P., Lev-Lehman, E., Tsai, T.F., Matsuura, T., Benton, C.S., Sutcliffe, J.S., Christian, S.L., Kubota, T., Halley, D.J. and Meijers-Heijboer, H. et al (1999) The spectrum of mutations in UBE3A causing Angelman syndrome. Hum. Mol. Genet. 8, 129-135
34. Nawaz, Z., Lonard, D.M., Smith, C.L., Lev-Lehman, E., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19, 1182-1189
35. Smith, C.L., DeVera, D.G., Lamb, D.J., Nawaz, Z., Jiang, Y.H., Beaudet, A.L. and O'Malley, B.W. (2002) Genetic ablation of the steroid receptor coactivator-Libiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Mol. Cell. Biol. 22, 525-535
36. Jordan, C. and Francke, U. (2006) Ube3a expression is not altered in Mecp2 mutant mice. Hum. Mol. Genet. 15, 2210-2215
37. Samaco, R.C., Hogart, A. and LaSalle, J.M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483-492
38. Jiang, Y.H., Armstrong, D., Albrecht, U., Atkins, C.M., Noebels, J.L., Eichele, G., Sweatt, J.D. and Beaudet, A.L. (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799-811
39. Miura, K., Kishino, T., Li, E., Webber, H., Dikkes, P., Holmes, G.L. and Wagstaff, J. (2002) Neurobehavioral and electroencephalographic abnormalities in Ube3a maternak-deficient mice. Neurobiol. Dis. 9, 149-159
40. Colas, D., Wagstaff, J., Fort, P., Salvert, D. and Sarda, N. (200S) Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome. Neurobiol. Dis. 20, 471-478
41. Albrecht, U., Sutcliffe, J.S., Cattanach, B.M., Beechey, C.V., Armstrong, D., Eichele, G. and Beaudet, A.L. (1997) Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 17, 75-78
42. Cheron, G., Servais, L., Wagstaff, J. and Dan, B. (200S) Fast cerebellar oscillation associated with ataxia in a mouse model of Angelman syndrome. Neuroscience 130, 631-637
43. Cheron, G., Servais, L., Dan, B., Gall, D., Roussel, C. and Schiffmann, S.N. (2005) Fast oscillation in the cerebellar cortex of calcium binding protein-deficient mice: a new sensorimotor arrest rhythm. Prog. Brain Res. 148, 165-180
44. Kumar, S., Talis, A.L. and Howley, P.M. (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J Biol. Chem. 274, 18785-18792
45. Oda, H., Kumar, S. and Howley, P.M. (1999) Regulation of the Src family tyrosine kinase Blk through F6AP-mediated ubiquitination. Proc. Natl. Acad. Sci. U.S.A. 96, 9557-9562
46. Thomas, M. and Banks, L. (1998) inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17, 2943-2954
47. Kuhne, C. and Banks, L. (1998) E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273, 34302-34309
48. Mani, A., Ch, A.S., Bowden, E.T., Lahusen, T., Lorick, K.L., Weissman, A.M., Schlegel, R., Wellstein, A. and Riegel, A.T. (2006) E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator Amplified in Breast Cancer 1 in immortalized cells. Cancer Res. 66, 8680-8686
49. Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B., Steen, H., Pandey, A. and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
50. Silva, J.C., Denny, R., Dorschel, C.A., Gorenstein, M., Kass, I.J., Li, G.Z., McKenna, T., Nold, M.J., Richardson, K., Young, P. and Geromanos, S. (2005) Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 77, 2187-2200
51. Butz, K., Denk, C., Ullmann, A., Scheffner, M. and Hoppe-Seyler, F. (2000) Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc. Natl. Acad. Sci. U.S.A. 97, 6693-6697